Schmeidl R - Search Results

1

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.

van Vollenhoven RF, Keystone EC, Strand V, Pacheco-Tena C, Vencovský J, Behrens F, Racewicz A, Zipp D, Rharbaoui F, Wolter R, Knierim L, Schmeidl R, Zhou X, Aigner S, Dälken B, Wartenberg-Demand A; TREAT2b study team. van Vollenhoven RF, et al. Among authors: schmeidl r. Ann Rheum Dis. 2018 Apr;77(4):495-499. doi: 10.1136/annrheumdis-2017-212478. Epub 2018 Jan 17. Ann Rheum Dis. 2018. PMID: 29343509 Clinical Trial.

2

Compliance and tolerability of subcutaneous hepatitis B immunoglobulin self-administration in liver transplant patients: a prospective, observational, multicenter study.

Klein CG, Cicinnati V, Schmidt H, Ganten T, Scherer MN, Braun F, Zeuzem S, Wartenberg-Demand A, Niemann G, Schmeidl R, Beckebaum S. Klein CG, et al. Among authors: schmeidl r. Ann Transplant. 2013 Dec 13;18:677-84. doi: 10.12659/AOT.889269. Ann Transplant. 2013. PMID: 24335787 Free article.

3

Safety monitoring of the intravenous immunoglobulin preparation Intratect® in primary and secondary immunodeficiencies: a prospective non-interventional study.

Bauhofer A, Dietrich RL, Schmeidl R. Bauhofer A, et al. Among authors: schmeidl r. Int J Clin Pharmacol Ther. 2015 Jan;53(1):21-31. doi: 10.5414/CP202204. Int J Clin Pharmacol Ther. 2015. PMID: 25345431

4

Predominant intraepithelial localization of primed T cells and immunoglobulin-producing lymphocytes in Graves' disease.

Paschke R, Brückner N, Schmeidl R, Pfiester P, Usadel KH. Paschke R, et al. Among authors: schmeidl r. Acta Endocrinol (Copenh). 1991 Jun;124(6):630-6. doi: 10.1530/acta.0.1240630. Acta Endocrinol (Copenh). 1991. PMID: 1829871

5

Extrathyroidal synthesis and biologic action of thyroid receptor antibody (TRAb) in Graves' disease.

Paschke R, Heinze HG, Teuber J, Schmeidl R, Usadel KH. Paschke R, et al. Among authors: schmeidl r. Acta Endocrinol Suppl (Copenh). 1987;281:352-4. doi: 10.1530/acta.0.114s352. Acta Endocrinol Suppl (Copenh). 1987. PMID: 3475918

6

[Results of clinical trials with the gluconeogenesis inhibitor 2-(3-methylcinnamylhydrazono)-propionate (MCHP)].

Paschke R, Schwedes U, Kühnle H, Peter J, Schmeidl R, Usadel KH. Paschke R, et al. Among authors: schmeidl r. Klin Wochenschr. 1989 Apr 17;67(8):431-7. doi: 10.1007/BF01725138. Klin Wochenschr. 1989. PMID: 2498571 Clinical Trial. German.

7

[Extrahepatic complications in chronic liver diseases: endocrine system].

Usadel KH, Schmeidl R. Usadel KH, et al. Among authors: schmeidl r. Z Gastroenterol Verh. 1986 Apr;21:35-40. Z Gastroenterol Verh. 1986. PMID: 2422838 German. No abstract available.

8

[Immune modulation therapy in type I diabetes mellitus].

Schmeidl R, Teuber J, Paschke R, Schwedes U, Usadel KH. Schmeidl R, et al. Fortschr Med. 1986 Dec 4;104(45):879-83. Fortschr Med. 1986. PMID: 3542769 German. No abstract available.

9

Management of type I diabetes with ciamexone.

Usadel KH, Teuber J, Schmeidl R, Schwedes U, Bicker U, Herz M. Usadel KH, et al. Among authors: schmeidl r. Lancet. 1986 Sep 6;2(8506):567. doi: 10.1016/s0140-6736(86)90128-5. Lancet. 1986. PMID: 2875293 No abstract available.

10

Evidence for a role of anti-idiotypic antibodies in the induction of remission in Graves' disease.

Paschke R, Teuber J, Enger I, Schmeidl R, Schwedes U, Usadel KH. Paschke R, et al. Among authors: schmeidl r. J Autoimmun. 1990 Aug;3(4):441-8. doi: 10.1016/s0896-8411(05)80011-3. J Autoimmun. 1990. PMID: 2222750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters